119 related articles for article (PubMed ID: 7957520)
1. Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine.
Kivistö KT; Kallio A; Neuvonen PJ
Eur J Clin Pharmacol; 1994; 46(4):345-9. PubMed ID: 7957520
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers.
Dyck JB; Maze M; Haack C; Vuorilehto L; Shafer SL
Anesthesiology; 1993 May; 78(5):813-20. PubMed ID: 8098190
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of intraspinal dexmedetomidine in sheep.
Eisenach JC; Shafer SL; Bucklin BA; Jackson C; Kallio A
Anesthesiology; 1994 Jun; 80(6):1349-59. PubMed ID: 7912045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine.
Scheinin H; Karhuvaara S; Olkkola KT; Kallio A; Anttila M; Vuorilehto L; Scheinin M
Clin Pharmacol Ther; 1992 Nov; 52(5):537-46. PubMed ID: 1358496
[TBL] [Abstract][Full Text] [Related]
5. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers.
Dyck JB; Maze M; Haack C; Azarnoff DL; Vuorilehto L; Shafer SL
Anesthesiology; 1993 May; 78(5):821-8. PubMed ID: 8098191
[TBL] [Abstract][Full Text] [Related]
6. Premedication with oral dexmedetomidine alters hemodynamic actions of intravenous anesthetic agents in chronically instrumented dogs.
Proctor LT; Schmeling WT; Warltier DC
Anesthesiology; 1992 Sep; 77(3):554-62. PubMed ID: 1355639
[TBL] [Abstract][Full Text] [Related]
7. Spinal and systemic action of the alpha 2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response.
Sabbe MB; Penning JP; Ozaki GT; Yaksh TL
Anesthesiology; 1994 May; 80(5):1057-72. PubMed ID: 7912480
[TBL] [Abstract][Full Text] [Related]
8. Mivazerol, a new alpha 2-adrenergic agonist, blunts cardiovascular effects following surgical stress in pentobarbital-anesthetized rats.
Zhang X; Wülfert E; Hanin I
Acta Anaesthesiol Scand; 1997 Jun; 41(6):694-700. PubMed ID: 9241327
[TBL] [Abstract][Full Text] [Related]
9. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.
Levänen J; Mäkelä ML; Scheinin H
Anesthesiology; 1995 May; 82(5):1117-25. PubMed ID: 7741286
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes.
Bloor BC; Ward DS; Belleville JP; Maze M
Anesthesiology; 1992 Dec; 77(6):1134-42. PubMed ID: 1361311
[TBL] [Abstract][Full Text] [Related]
12. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine.
Talke P; Richardson CA; Scheinin M; Fisher DM
Anesth Analg; 1997 Nov; 85(5):1136-42. PubMed ID: 9356115
[TBL] [Abstract][Full Text] [Related]
13. Systemic absorption and systemic effects of ocularly administered dexmedetomidine in rabbits.
MacDonald E; Vartiainen J; Jäsberg K; Vuorilehto L; Salonen JS; Urtti A
Curr Eye Res; 1993 May; 12(5):451-60. PubMed ID: 8102091
[TBL] [Abstract][Full Text] [Related]
14. Oral dexmedetomidine attenuates hemodynamic responses during emergence from general anesthesia in chronically instrumented dogs.
Proctor LT; Schmeling WT; Roerig D; Kampine JP; Warltier DC
Anesthesiology; 1991 Jan; 74(1):108-14. PubMed ID: 1670911
[TBL] [Abstract][Full Text] [Related]
15. Intravenous dexmedetomidine inhibits cerebrovascular dilation induced by isoflurane and sevoflurane in dogs.
Ohata H; Iida H; Dohi S; Watanabe Y
Anesth Analg; 1999 Aug; 89(2):370-7. PubMed ID: 10439750
[TBL] [Abstract][Full Text] [Related]
16. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms.
Kallio A; Scheinin M; Koulu M; Ponkilainen R; Ruskoaho H; Viinamäki O; Scheinin H
Clin Pharmacol Ther; 1989 Jul; 46(1):33-42. PubMed ID: 2568211
[TBL] [Abstract][Full Text] [Related]
17. The effects of dexmedetomidine on neuromuscular blockade in human volunteers.
Talke PO; Caldwell JE; Richardson CA; Kirkegaard-Nielsen H; Stafford M
Anesth Analg; 1999 Mar; 88(3):633-9. PubMed ID: 10072019
[TBL] [Abstract][Full Text] [Related]
18. A comparison of dexmedetomidine, and alpha 2-adrenoceptor agonist, and midazolam as i.m. premedication for minor gynaecological surgery.
Aantaa R; Jaakola ML; Kallio A; Kanto J; Scheinin M; Vuorinen J
Br J Anaesth; 1991 Oct; 67(4):402-9. PubMed ID: 1681840
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine as intramuscular premedication for day-case cataract surgery. A comparative study of dexmedetomidine, midazolam and placebo.
Virkkilä M; Ali-Melkkilä T; Kanto J; Turunen J; Scheinin H
Anaesthesia; 1994 Oct; 49(10):853-8. PubMed ID: 7802178
[TBL] [Abstract][Full Text] [Related]
20. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine.
Zornow MH
Neuropharmacology; 1991 Oct; 30(10):1065-71. PubMed ID: 1684646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
